Swindon & Wiltshire News
New medical manufacturer acquires production facility with HSBC funding
A newly-formed medical device manufacturing business has secured a seven-figure funding package from HSBC UK to acquire a major medical technology production facility in Swindon.
Quvara Medical, part of the Buckland Group, which specialises in the production of autoinjectors, pen injectors and precision components for pharmaceutical and biotech partners, has used the funding to acquire the site from global medical technology company Becton Dickinson.
The deal includes the freehold property, plant and advanced manufacturing equipment, such as automated moulding lines and validated cleanroom assembly facilities.
Additionally, the acquisition has seen more than 300 employees transfer to Quvara Medical and provided working capital to support ongoing operations.
The site will continue manufacturing Becton Dickinson products under a partnership agreement, building on three decades of specialist expertise in advanced drug-delivery systems.
The funding will also expand training opportunities for young engineers and strengthen relationships with Swindon-based suppliers over the coming years.
Andy Wertheim, chief commercial officer at Quvara Medical: “This funding is pivotal for the launch of Quvara Medical as a new manufacturer.
“The Swindon production facility has a strong track record in advanced drug-delivery device manufacturing and, with HSBC UK’s support, we’ve been able to acquire the site fully certified to the required medical and quality standards, allowing us to begin operations immediately while maintaining continuity for existing customers.
“As we begin this next chapter as an independent business, we’re looking forward to building closer relationships with suppliers across Swindon and the wider Wiltshire areas.
“Those partnerships will be an important part of how we expand our manufacturing footprint, broaden our customer base and support growth across the UK and European markets.”
Andy Farmer, corporate relationship director at HSBC UK said: “Quvara Medical has a clear strategic vision supported by a strong operational foundation.
“Providing this funding reflects our commitment to championing high-value UK manufacturing and supporting businesses with deep technical expertise and long-term growth potential.
“This investment will also help sustain skilled jobs in Swindon and further strengthen the region’s advanced manufacturing base.”
